Idera Pharmaceuticals, Inc. (NASDAQ:IDRA)

CAPS Rating: 2 out of 5

The Company is engaged in the discovery and development of synthetic DNA and RNA-based compounds for the treatment of cancer, infectious diseases, autoimmune diseases, and asthma/allergies, and for use as vaccine adjuvants.

Results 1 - 18 of 18

Recs

0
Member Avatar pchop123 (76.55) Submitted: 5/22/2013 3:44:43 PM : Underperform Start Price: $0.69 IDRA Score: -0.83

short

Recs

0
Member Avatar import2udirect (< 20) Submitted: 5/4/2012 5:19:01 AM : Outperform Start Price: $1.14 IDRA Score: -58.48

I do believe Dna and blood will be the future detection of cancer if its not already happening now I remember seeing something on the news about being able to detect cancer by blood maybe this company has a hold on this concept if so long

Recs

0
Member Avatar ExtremesTracker (83.65) Submitted: 12/7/2010 6:11:40 PM : Outperform Start Price: $2.45 IDRA Score: -106.17

picks source: zzlangerhans
as of 12/7/2010, these were the 5 most underperformed designated "top picks" by zz. these are the 5 picks (out 7 top picks):
alny,idra,rtix,biod,bdsi
No due diligence performed, these are hail marys that atleast a couple may possibly be insane multi baggers potentially
Very risky.

Recs

1
Member Avatar BillyTG (32.74) Submitted: 10/21/2010 10:50:32 AM : Outperform Start Price: $2.91 IDRA Score: -115.23

rfaramir follow on zzlangerhan's follow on portefeuille's rec of his rec

Recs

0
Member Avatar chicachick (72.48) Submitted: 10/12/2010 3:48:03 PM : Outperform Start Price: $3.01 IDRA Score: -118.14

Bravobevo

Recs

0
Member Avatar LongShortIndex (33.07) Submitted: 7/6/2010 4:45:02 AM : Outperform Start Price: $3.53 IDRA Score: -139.95

medical/biotech related picks - 4 buys / 4 sells
BUY:exel,idra,rtix,dcth
SELL:pbth,pcyc,vrtx,nbix

Recs

0
Member Avatar Bumkinpops (< 20) Submitted: 5/9/2010 11:44:00 AM : Outperform Start Price: $4.89 IDRA Score: -127.55

Technology platform with great potential.

Recs

0
Member Avatar pjani06 (30.05) Submitted: 3/25/2010 1:20:41 AM : Outperform Start Price: $5.65 IDRA Score: -128.35

stock picks with the potential of being doublers to multibaggers, yet risky, very risky and can go nearly to 0. hated by CAPs, but they have atleast 1 CAPs allstar that I like that has greenthumbed this one. These things have been beaten, and if 2 of 6 of em double, and another 2 don't even move, well it makes up if the last 2 go to zero n basically tank.
DMAN, FSLR, IDRA, ARQL, OSIR, MDVN

Recs

1
Member Avatar ScreenerStizBear (28.27) Submitted: 6/26/2008 2:26:22 PM : Underperform Start Price: $14.63 IDRA Score: +127.57

I simply used the screener to identify 1-star companies with the highest 52-week gain. The 1-star rating should mean they are bad companies and the 52-week gain should mean they are overpriced. We’ll see how it works!

Recs

0
Member Avatar goldnrtrvrlvr (41.04) Submitted: 5/5/2008 7:24:39 AM : Outperform Start Price: $14.75 IDRA Score: -116.93

New Hi

Recs

0
Member Avatar fouadtawfig (< 20) Submitted: 4/16/2008 11:27:35 AM : Outperform Start Price: $13.03 IDRA Score: -121.55

exiting patents needed for farmuecitical market will reflect son expanded orders and deman for larger supply.

Recs

0
Member Avatar mbeleza (< 20) Submitted: 11/14/2007 5:56:55 AM : Underperform Start Price: $12.15 IDRA Score: +110.44

It´s at it's most

Recs

0
Member Avatar eXigy (59.50) Submitted: 9/5/2007 2:59:30 PM : Underperform Start Price: $8.80 IDRA Score: +110.18

Not a long-termie, because I'm not personally well into the stock and cannot tell whether they have something unique in their safes to take it out by Easter or not.
But I can tell a stock with such stats and such current price is to go down.

Recs

0
Member Avatar fire0821 (< 20) Submitted: 6/21/2007 10:12:51 PM : Outperform Start Price: $6.87 IDRA Score: -104.83

pharmaceuticals are always fluctuating up and down according to the seasons. summer is a down season.

Recs

0
Member Avatar TyPicks (< 20) Submitted: 2/8/2007 11:02:07 AM : Outperform Start Price: $9.40 IDRA Score: -114.27

Wall Street Pro Pick.

Recs

0
Member Avatar davezzzz (50.87) Submitted: 1/26/2007 7:51:21 PM : Outperform Start Price: $7.67 IDRA Score: -114.44

Hey - it's just a random pick from the top performers list. What do I know? (not much)

Recs

1
Member Avatar lemapud (< 20) Submitted: 1/22/2007 5:20:24 PM : Outperform Start Price: $7.70 IDRA Score: -114.42

IDERA has cutting edge new science in the field of immunology. They have had their share of followers and detractors over the years, and survived through it all. They have a strong company plan now, good partners, and exciting therapies that will be used to combat aids, cancer, and other human maladies. Above all IDERA has always been an honest, intelligent company that had strived to make a difference in health and science.

Recs

0
Member Avatar martinlemalin (< 20) Submitted: 1/20/2007 4:34:19 PM : Outperform Start Price: $7.55 IDRA Score: -113.54

.. I'd give this one a thumbs up ..

Results 1 - 18 of 18

Featured Broker Partners


Advertisement